查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1887135

分子影像市场规模、占有率、成长及全球产业分析：依类型、应用和地区划分的洞察与预测（2024-2032 年）

Molecular Imaging Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 180 Pages | 商品交期: 请询问到货日

价格

分子影像市场成长推动因素

随着医疗保健系统扩大采用精准诊断技术来改善疾病检测和治疗监测，全球分子影像市场持续发展。根据最新的行业评估，该市场在 2024 年的价值为 21.9 亿美元，到 2025 年增长至 23.2 亿美元，预计到 2032 年将达到 34.6 亿美元。这一成长的推动因素包括慢性病盛行率的上升、PET 和 SPECT 影像技术的创新，以及已开发市场和新兴市场医疗保健基础设施的不断改进。

市场趋势与主要成长推动因素

分子影像透过在细胞和分子层面上可视化生物过程，在复杂疾病的诊断中发挥关键作用。对先进影像系统的需求持续成长，主要原因是癌症、神经系统疾病和心血管疾病病例的增加。美国国家癌症研究所（2024 年）预测，2024 年美国将新增 200 万例癌症病例，凸显了改善诊断工具的迫切需求。

推动 2024 年和 2025 年市场成长的关键因素是老龄人口的快速成长。根据皮尤研究中心 2024 年的报告，美国 65 岁以上老年人口为 6,200 万，预计到 2054 年将达到 8,400 万人。老年人口易患阿兹海默症、帕金森氏症和肌肉骨骼疾病，进一步推动了全球对 PET 和 SPECT 扫描仪的需求。

此外，GE医疗、西门子医疗、佳能医疗和飞利浦等主要製造商持续加强研发投入，推出PET/CT和SPECT/CT等先进的混合影像系统。这些技术提高了诊断准确率，并缩短了扫描时间。

市场限制因子

儘管分子影像技术具有显着优势，但高昂的投资成本限制了其在中低收入地区的普及。新型PET/CT扫描仪的售价在50万美元至500万美元之间，对许多医疗机构构成了经济障碍。此外，价格低廉得多的翻新设备市场（25万至45万美元）正在不断扩大，对新系统构成了激烈的竞争，尤其是在新兴市场。

医疗应用领域的机会

预计到2032年，随着分子影像技术在心臟病学、肿瘤学、神经病学、骨科、妇科等领域的应用不断扩展，将迎来显着的成长机会。即时分子影像技术因其快速出结果和易于操作而日益普及。根据美国国家生物技术资讯中心（NCBI）2021年的一项调查，93%的美国受访者认为即时检测（POC​​T）有助于提高医疗保健质量，促使更多医院和诊断中心投资购买先进的扫描仪。

个人化医疗和精准肿瘤学的进步进一步加速了对分子影像的需求。 PET和SPECT扫描能够即时评估治疗效果，使医生能够更有效地制定个人化治疗方案。

细分市场分析

依类型

2024年，正子断层扫描（PET）成为领先细分市场，这主要得益于神经系统疾病和肿瘤病例的增加。根据世界卫生组织（WHO）的报告，加拿大PET扫描仪的普及率很高，每百万人拥有1.48台PET扫描仪。随着製造商推出更经济高效的系统，SPECT技术预计将在2032年之前稳步成长。

依应用

2024年，由于全球癌症负担日益加重，肿瘤学成为领先领域。美国每年报告的骨科损伤相关住院病例达360万例，骨科应用也不断扩展。由于慢性神经系统疾病的增加，预计到 2032 年，神经病学领域将显着增长。

依最终使用者划分

由于越来越多的患者寻求更短的等待时间和更先进的影像检查方案，诊断影像中心预计将成长最快。截至 2023 年，美国将拥有约 19,000 家影像中心，体现了该领域的规模。

区域展望

北美

截至 2024 年，北美地区是最大的市场，其分子影像市值达 9.6 亿美元。该地区强劲的医疗保健支出、对先进技术的早期应用以及主要製造商的存在，预计将支撑其在2032年之前继续保持领先地位。

欧洲

成长的推动力在于PET/CT和SPECT扫描仪的日益普及以及政府对诊断影像研究的支持。荷兰以每百万人拥有2.33台PET扫描器位居榜首。

亚太地区

预计该地区将实现最快增长，这得益于不断增长的医疗保健投资和庞大的老龄人口。到2023年，光是中国就有2.97亿60岁以上人口。

目录

第一章：引言

第二章：摘要整理

第三章：市场动态

  • 市场推动因素
  • 市场阻碍因素
  • 市场机遇
  • 市场趋势

第四章：主要发现

  • 主要国家和地区主要疾病盛行率（2023/2024）
  • 分子影像仪器的技术进步
  • 主要国家和地区的安装量（2023/2024）
  • 新产品发布状况主要公司
  • 关键产业趋势：併购与合作
  • 新冠疫情对市场的影响

第五章：全球分子影像市场分析、洞察与预测（2019-2032）

  • 市场分析、洞察与预测 - 依类型划分
    • 正子断层扫描 (PET)
    • 单光子发射电脑断层扫描 (SPECT)
    • 其他
  • 市场分析、洞察与预测 - 依应用划分
    • 心臟病学
    • 肿瘤学
    • 骨科
    • 妇科
    • 神经病学
    • 其他
  • 市场分析、洞察与预测 - 依最终用途划分用户
    • 医院
    • 专科诊所
    • 诊断影像中心
    • 其他
  • 市场分析、洞察与预测 - 依地区划分
    • 北美
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲

第六章：北美分子影像市场分析、洞察与预测（2019-2032）

  • 依国家划分
    • 美国
    • 加拿大

第七章：欧洲分子影像市场分析、洞察与预测（2019-2032）

  • 依国家划分
    • 美国王国
    • 德国
    • 法国
    • 西班牙
    • 义大利
    • 斯堪的纳维亚
    • 欧洲其他地区

第八章 亚太分子影像市场分析、洞察与预测（2019-2032）

  • 依国家划分
    • 日本
    • 澳大利亚
    • 中国
    • 印度
    • 东南亚
    • 亚太其他地区

第九章 拉丁美洲分子影像市场分析、洞察与预测（2019-2032）

  • 依国家划分
    • 巴西
    • 墨西哥
    • 拉丁美洲其他地区美国

第十章：中东与非洲分子影像市场分析、洞察与预测（2019-2032）

  • 依国家划分
    • 海湾合作委员会 (GCC)
    • 南非
    • 中东和非洲其他地区

第十一章 竞争分析

  • 全球市占率分析（2024）
  • 公司简介
    • 通用电气医疗集团 (GE Healthcare)
    • 西门子医疗 (Siemens Healthineers AG)
    • 皇家飞利浦公司 (Koninklijke Philips N.V.)
    • 岛津公司 (Shimadzu Corporation)
    • 佳能医疗系统株式会社 (CANON MEDICAL SYSTEMS CORPORATION)
    • 布鲁克 (Bruker)
    • 兰特斯控股公司 (Lantheus Holdings, Inc.)
    • 世上导引株式会社 (Segami Corporation)
Product Code: FBI112879

Growth Factors of molecular imaging Market

The global molecular imaging market continues to advance as healthcare systems increasingly adopt precision diagnostic technologies to improve disease detection and treatment monitoring. According to the latest industry assessments, the market was valued at USD 2.19 billion in 2024 and is projected to grow to USD 2.32 billion in 2025, reaching USD 3.46 billion by 2032. This growth is attributed to rising chronic disease prevalence, technological innovations in PET and SPECT imaging, and expanding healthcare infrastructure in developed and emerging markets.

Market Insights and Key Growth Factors

Molecular imaging plays a crucial role in diagnosing complex diseases by visualizing biological processes at the cellular and molecular levels. Demand for advanced imaging systems continues to rise, primarily due to increasing cases of cancer, neurological disorders, and cardiovascular conditions. The National Cancer Institute (2024) anticipates 2.0 million new cancer cases in the U.S. in 2024, demonstrating the urgent need for improved diagnostic tools.

A significant driver for the market in 2024 and 2025 is the rapid growth of the geriatric population. The Pew Research Center (2024) reported that 62 million adults aged 65+ live in the U.S., expected to reach 84 million by 2054. This aging demographic is more susceptible to Alzheimer's disease, Parkinson's disease, and musculoskeletal conditions-further supporting the need for more PET and SPECT scanners worldwide.

Additionally, leading manufacturers such as GE Healthcare, Siemens Healthineers AG, Canon Medical, and Philips continue to invest in R&D, introducing advanced hybrid imaging systems such as PET/CT and SPECT/CT, which improve diagnostic accuracy and shorten scan times.

Market Restraints

Despite its significant benefits, molecular imaging technology involves high investment costs, limiting adoption in low- and middle-income regions. A new PET/CT scanner costs between USD 0.5 million and USD 5.0 million, creating a financial barrier for many healthcare facilities. Moreover, the growing market for refurbished equipment-priced significantly lower at USD 0.25 million to USD 0.45 million-poses strong competition for new system installations, especially in emerging markets.

Opportunities in Medical Applications

The expanding use of molecular imaging across cardiology, oncology, neurology, orthopedics, and gynecology offers substantial growth opportunities through 2032. Point-of-care molecular imaging is gaining adoption due to faster results and better accessibility. According to a 2021 NCBI survey, 93% of respondents in the U.S. believed POCT improved their care, encouraging more hospitals and diagnostic centers to invest in advanced scanners.

Personalized medicine and precision oncology are further accelerating the demand for molecular imaging. PET and SPECT scans enable real-time evaluation of treatment responses, allowing physicians to tailor therapies more effectively.

Segmentation Analysis

By Type

In 2024, Positron Emission Tomography (PET) was the leading segment, driven by increasing neurological and oncological cases. The WHO reported 1.48 PET scanners per million population in Canada, highlighting strong adoption rates. SPECT technology is expected to grow steadily through 2032 as manufacturers introduce more affordable and efficient systems.

By Application

The oncology segment dominated in 2024 due to an escalating global cancer burden. Orthopedic applications also expanded, supported by 3.6 million orthopedic injury-related hospital visits annually in the U.S. Neurology is anticipated to rise significantly through 2032 as chronic neurological disorders become more common.

By End-User

Diagnostic imaging centers are growing fastest due to greater patient preference for shorter wait times and advanced imaging options. The U.S. had about 19,000 imaging centers in 2023, showcasing the scale of this segment.

Regional Outlook

North America

The largest market in 2024, North America recorded USD 0.96 billion in molecular imaging value. Strong healthcare spending, early adoption of advanced technology, and leading manufacturers in the region support continued dominance through 2032.

Europe

Growth is driven by increasing PET/CT and SPECT installations and government support for imaging research. The Netherlands leads with 2.33 PET scanners per million population.

Asia Pacific

Expected to be the fastest-growing region, supported by rising healthcare investment and a large elderly population. China alone recorded 297 million people aged 60+ in 2023.

Conclusion

With market value rising from USD 2.19 billion in 2024 to USD 2.32 billion in 2025, and projected to reach USD 3.46 billion by 2032, the molecular imaging market is poised for substantial expansion. Advancements in PET and SPECT technology, increasing chronic disease prevalence, and strong demand for precision diagnostics will sustain growth over the forecast period.

a DETAILS

Segmentation By Type

  • Positron Emission Tomography (PET)
  • Single Photon Emission Computed Tomography (SPECT)
  • Others

By Application

  • Cardiology
  • Oncology
  • Orthopedics
  • Gynecology
  • Neurology
  • Others

By End-user

  • Hospitals
  • Specialty Clinics
  • Diagnostic Imaging Centers
  • Others

By Geography

  • North America (By Type, Application, End-user, and Country)
    • U.S.
    • Canada
  • Europe (By Type, Application, End-user, and Country/Sub-region)
    • Germany
    • U.K.
    • France
    • Spain
    • Italy
    • Scandinavia
    • Rest of Europe
  • Asia Pacific (By Type, Application, End-user, and Country/Sub-region)
    • China
    • Japan
    • India
    • Australia
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America (By Type, Application, End-user, and Country/Sub-region)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa (By Type, Application, End-user, and Country/Sub-region)
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Prevalence of Key Disorders, Key Countries/Regions, 2023/2024
  • 4.2. Technological Advancements in Molecular Imaging Equipment
  • 4.3. Installed Base, Key Countries/Regions, 2023/2024
  • 4.4. New Product Launches, Key Players
  • 4.5. Key Industry Developments - Mergers, Acquisitions & Partnerships
  • 4.6. Impact of COVID-19 on the Market

5. Global Molecular Imaging Market Analysis, Insights and Forecast, 2019-2032

  • 5.1. Market Analysis, Insights and Forecast - By Type
    • 5.1.1. Positron Emission Tomography (PET)
    • 5.1.2. Single-Photon Emission Computed Tomography (SPECT)
    • 5.1.3. Others
  • 5.2. Market Analysis, Insights and Forecast - By Application
    • 5.2.1. Cardiology
    • 5.2.2. Oncology
    • 5.2.3. Orthopedics
    • 5.2.4. Gynecology
    • 5.2.5. Neurology
    • 5.2.6. Others
  • 5.3. Market Analysis, Insights and Forecast - By End User
    • 5.3.1. Hospitals
    • 5.3.2. Specialty Clinics
    • 5.3.3. Diagnostic Imaging Centers
    • 5.3.4. Others
  • 5.4. Market Analysis, Insights and Forecast - By Region
    • 5.4.1. North America
    • 5.4.2. Europe
    • 5.4.3. Asia Pacific
    • 5.4.4. Latin America
    • 5.4.5. Middle East & Africa

6. North America Molecular Imaging Market Analysis, Insights and Forecast, 2019-2032

  • 6.1. Market Analysis, Insights and Forecast - By Type
    • 6.1.1. Positron Emission Tomography (PET)
    • 6.1.2. Single-Photon Emission Computed Tomography (SPECT)
    • 6.1.3. Others
  • 6.2. Market Analysis, Insights and Forecast - By Application
    • 6.2.1. Cardiology
    • 6.2.2. Oncology
    • 6.2.3. Orthopedics
    • 6.2.4. Gynecology
    • 6.2.5. Neurology
    • 6.2.6. Others
  • 6.3. Market Analysis, Insights and Forecast - By End User
    • 6.3.1. Hospitals
    • 6.3.2. Specialty Clinics
    • 6.3.3. Diagnostic Imaging Centers
    • 6.3.4. Others
  • 6.4. Market Analysis, Insights and Forecast - By Country
    • 6.4.1. U.S.
    • 6.4.2. Canada

7. Europe Molecular Imaging Market Analysis, Insights and Forecast, 2019-2032

  • 7.1. Market Analysis, Insights and Forecast - By Type
    • 7.1.1. Positron Emission Tomography (PET)
    • 7.1.2. Single-Photon Emission Computed Tomography (SPECT)
    • 7.1.3. Others
  • 7.2. Market Analysis, Insights and Forecast - By Application
    • 7.2.1. Cardiology
    • 7.2.2. Oncology
    • 7.2.3. Orthopedics
    • 7.2.4. Gynecology
    • 7.2.5. Neurology
    • 7.2.6. Others
  • 7.3. Market Analysis, Insights and Forecast - By End User
    • 7.3.1. Hospitals
    • 7.3.2. Specialty Clinics
    • 7.3.3. Diagnostic Imaging Centers
    • 7.3.4. Others
  • 7.4. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 7.4.1. U.K.
    • 7.4.2. Germany
    • 7.4.3. France
    • 7.4.4. Spain
    • 7.4.5. Italy
    • 7.4.6. Scandinavia
    • 7.4.7. Rest of Europe

8. Asia pacific Molecular Imaging Market Analysis, Insights and Forecast, 2019-2032

  • 8.1. Market Analysis, Insights and Forecast - By Type
    • 8.1.1. Positron Emission Tomography (PET)
    • 8.1.2. Single-Photon Emission Computed Tomography (SPECT)
    • 8.1.3. Others
  • 8.2. Market Analysis, Insights and Forecast - By Application
    • 8.2.1. Cardiology
    • 8.2.2. Oncology
    • 8.2.3. Orthopedics
    • 8.2.4. Gynecology
    • 8.2.5. Neurology
    • 8.2.6. Others
  • 8.3. Market Analysis, Insights and Forecast - By End User
    • 8.3.1. Hospitals
    • 8.3.2. Specialty Clinics
    • 8.3.3. Diagnostic Imaging Centers
    • 8.3.4. Others
  • 8.4. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 8.4.1. Japan
    • 8.4.2. Australia
    • 8.4.3. China
    • 8.4.4. India
    • 8.4.5. Southeast Asia
    • 8.4.6. Rest of Asia Pacific

9. Latin America Molecular Imaging Market Analysis, Insights and Forecast, 2019-2032

  • 9.1. Market Analysis, Insights and Forecast - By Type
    • 9.1.1. Positron Emission Tomography (PET)
    • 9.1.2. Single-Photon Emission Computed Tomography (SPECT)
    • 9.1.3. Others
  • 9.2. Market Analysis, Insights and Forecast - By Application
    • 9.2.1. Cardiology
    • 9.2.2. Oncology
    • 9.2.3. Orthopedics
    • 9.2.4. Gynecology
    • 9.2.5. Neurology
    • 9.2.6. Others
  • 9.3. Market Analysis, Insights and Forecast - By End User
    • 9.3.1. Hospitals
    • 9.3.2. Specialty Clinics
    • 9.3.3. Diagnostic Imaging Centers
    • 9.3.4. Others
  • 9.4. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 9.4.1. Brazil
    • 9.4.2. Mexico
    • 9.4.3. Rest of Latin America

10. Middle East & Africa Molecular Imaging Market Analysis, Insights and Forecast, 2019-2032

  • 10.1. Market Analysis, Insights and Forecast - By Type
    • 10.1.1. Positron Emission Tomography (PET)
    • 10.1.2. Single-Photon Emission Computed Tomography (SPECT)
    • 10.1.3. Others
  • 10.2. Market Analysis, Insights and Forecast - By Application
    • 10.2.1. Cardiology
    • 10.2.2. Oncology
    • 10.2.3. Orthopedics
    • 10.2.4. Gynecology
    • 10.2.5. Neurology
    • 10.2.6. Others
  • 10.3. Market Analysis, Insights and Forecast - By End User
    • 10.3.1. Hospitals
    • 10.3.2. Specialty Clinics
    • 10.3.3. Diagnostic Imaging Centers
    • 10.3.4. Others
  • 10.4. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 10.4.1. GCC
    • 10.4.2. South Africa
    • 10.4.3. Rest of Middle East & Africa

11. Competitive Analysis

  • 11.1. Global Market Share Analysis (2024)
  • 11.2. Company Profiles
    • 11.2.1. GE Healthcare
      • 11.2.1.1. Overview
      • 11.2.1.2. Products
      • 11.2.1.3. SWOT Analysis
      • 11.2.1.4. Recent Developments
      • 11.2.1.5. Strategies
      • 11.2.1.6. Financials (Based on Availability)
    • 11.2.2. Siemens Healthineers AG
      • 11.2.2.1. Overview
      • 11.2.2.2. Products
      • 11.2.2.3. SWOT Analysis
      • 11.2.2.4. Recent Developments
      • 11.2.2.5. Strategies
      • 11.2.2.6. Financials (Based on Availability)
    • 11.2.3. Koninklijke Philips N.V.
      • 11.2.3.1. Overview
      • 11.2.3.2. Products
      • 11.2.3.3. SWOT Analysis
      • 11.2.3.4. Recent Developments
      • 11.2.3.5. Strategies
      • 11.2.3.6. Financials (Based on Availability)
    • 11.2.4. Shimadzu Corporation
      • 11.2.4.1. Overview
      • 11.2.4.2. Products
      • 11.2.4.3. SWOT Analysis
      • 11.2.4.4. Recent Developments
      • 11.2.4.5. Strategies
      • 11.2.4.6. Financials (Based on Availability)
    • 11.2.5. CANON MEDICAL SYSTEMS CORPORATION
      • 11.2.5.1. Overview
      • 11.2.5.2. Products
      • 11.2.5.3. SWOT Analysis
      • 11.2.5.4. Recent Developments
      • 11.2.5.5. Strategies
      • 11.2.5.6. Financials (Based on Availability)
    • 11.2.6. Bruker
      • 11.2.6.1. Overview
      • 11.2.6.2. Products
      • 11.2.6.3. SWOT Analysis
      • 11.2.6.4. Recent Developments
      • 11.2.6.5. Strategies
      • 11.2.6.6. Financials (Based on Availability)
    • 11.2.7. Lantheus Holdings, Inc.
      • 11.2.7.1. Overview
      • 11.2.7.2. Products
      • 11.2.7.3. SWOT Analysis
      • 11.2.7.4. Recent Developments
      • 11.2.7.5. Strategies
      • 11.2.7.6. Financials (Based on Availability)
    • 11.2.8. Segami Corporation
      • 11.2.8.1. Overview
      • 11.2.8.2. Products
      • 11.2.8.3. SWOT Analysis
      • 11.2.8.4. Recent Developments
      • 11.2.8.5. Strategies
      • 11.2.8.6. Financials (Based on Availability)

List of Tables

  • Table 1: Global Molecular Imaging Market Revenue (USD billion) Forecast, by Type, 2019-2032
  • Table 2: Global Molecular Imaging Market Revenue (USD billion) Forecast, by Application, 2019-2032
  • Table 3: Global Molecular Imaging Market Revenue (USD billion) Forecast, by End User, 2019-2032
  • Table 4: Global Molecular Imaging Market Revenue (USD billion) Forecast, by Region, 2019-2032
  • Table 5: North America Molecular Imaging Market Revenue (USD billion) Forecast, by Type, 2019-2032
  • Table 6: North America Molecular Imaging Market Revenue (USD billion) Forecast, by Application, 2019-2032
  • Table 7: North America Molecular Imaging Market Revenue (USD billion) Forecast, by End User, 2019-2032
  • Table 8: North America Molecular Imaging Market Revenue (USD billion) Forecast, By Country, 2019-2032
  • Table 9: Europe Molecular Imaging Market Revenue (USD billion) Forecast, by Type, 2019-2032
  • Table 10: Europe Molecular Imaging Market Revenue (USD billion) Forecast, by Application, 2019-2032
  • Table 11: Europe Molecular Imaging Market Revenue (USD billion) Forecast, by End User, 2019-2032
  • Table 12: Europe Molecular Imaging Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032
  • Table 13: Asia Pacific Molecular Imaging Market Revenue (USD billion) Forecast, by Type, 2019-2032
  • Table 14: Asia Pacific Molecular Imaging Market Revenue (USD billion) Forecast, by Application, 2019-2032
  • Table 15: Asia Pacific Molecular Imaging Market Revenue (USD billion) Forecast, by End User, 2019-2032
  • Table 16: Asia Pacific Molecular Imaging Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032
  • Table 17: Latin America Molecular Imaging Market Revenue (USD billion) Forecast, by Type, 2019-2032
  • Table 18: Latin America Molecular Imaging Market Revenue (USD billion) Forecast, by Application, 2019-2032
  • Table 19: Latin America Molecular Imaging Market Revenue (USD billion) Forecast, by End User, 2019-2032
  • Table 20: Latin America Molecular Imaging Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032
  • Table 21: Middle East & Africa Molecular Imaging Market Revenue (USD billion) Forecast, by Type, 2019-2032
  • Table 22: Middle East & Africa Molecular Imaging Market Revenue (USD billion) Forecast, by Application, 2019-2032
  • Table 23: Middle East & Africa Molecular Imaging Market Revenue (USD billion) Forecast, by End User, 2019-2032
  • Table 24: Middle East & Africa Molecular Imaging Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032

List of Figures

  • Figure 1: Global Molecular Imaging Market Revenue Breakdown (USD billion, %) by Region, 2024 & 2032
  • Figure 2: Global Molecular Imaging Market Value Share (%), by Type, 2024 & 2032
  • Figure 3: Global Molecular Imaging Market Value Share (%), by Application, 2024 & 2032
  • Figure 4: Global Molecular Imaging Market Value Share (%), by End User, 2024 & 2032
  • Figure 5: Global Molecular Imaging Market Value Share (%), by Region, 2024 & 2032
  • Figure 6: North America Molecular Imaging Market Value (USD billion), by Type, 2024 & 2032
  • Figure 7: North America Molecular Imaging Market Value Share (%), by Type, 2024
  • Figure 8: North America Molecular Imaging Market Value (USD billion), by Application, 2024 & 2032
  • Figure 9: North America Molecular Imaging Market Value Share (%), by Application, 2024
  • Figure 10: North America Molecular Imaging Market Value (USD billion), by End User, 2024 & 2032
  • Figure 11: North America Molecular Imaging Market Value Share (%), by End User, 2024
  • Figure 12: North America Molecular Imaging Market Value (USD billion), By Country, 2024 & 2032
  • Figure 13: North America Molecular Imaging Market Value Share (%), By Country, 2024
  • Figure 14: Europe Molecular Imaging Market Value (USD billion), by Type, 2024 & 2032
  • Figure 15: Europe Molecular Imaging Market Value Share (%), by Type, 2024
  • Figure 16: Europe Molecular Imaging Market Value (USD billion), by Application, 2024 & 2032
  • Figure 17: Europe Molecular Imaging Market Value Share (%), by Application, 2024
  • Figure 18: Europe Molecular Imaging Market Value (USD billion), by End User, 2024 & 2032
  • Figure 19: Europe Molecular Imaging Market Value Share (%), by End User, 2024
  • Figure 20: Europe Molecular Imaging Market Value (USD billion), By Country/ Sub-region, 2024 & 2032
  • Figure 21: Europe Molecular Imaging Market Value Share (%), By Country/ Sub-region, 2024
  • Figure 22: Asia Pacific Molecular Imaging Market Value (USD billion), by Type, 2024 & 2032
  • Figure 23: Asia Pacific Molecular Imaging Market Value Share (%), by Type, 2024
  • Figure 24: Asia Pacific Molecular Imaging Market Value (USD billion), by Application, 2024 & 2032
  • Figure 25: Asia Pacific Molecular Imaging Market Value Share (%), by Application, 2024
  • Figure 26: Asia Pacific Molecular Imaging Market Value (USD billion), by End User, 2024 & 2032
  • Figure 27: Asia Pacific Molecular Imaging Market Value Share (%), by End User, 2024
  • Figure 28: Asia Pacific Molecular Imaging Market Value (USD billion), By Country/ Sub-region, 2024 & 2032
  • Figure 29: Asia Pacific Molecular Imaging Market Value Share (%), By Country/ Sub-region, 2024
  • Figure 30: Latin America Molecular Imaging Market Value (USD billion), by Type, 2024 & 2032
  • Figure 31: Latin America Molecular Imaging Market Value Share (%), by Type, 2024
  • Figure 32: Latin America Molecular Imaging Market Value (USD billion), by Application, 2024 & 2032
  • Figure 33: Latin America Molecular Imaging Market Value Share (%), by Application, 2024
  • Figure 34: Latin America Molecular Imaging Market Value (USD billion), by End User, 2024 & 2032
  • Figure 35: Latin America Molecular Imaging Market Value Share (%), by End User, 2024
  • Figure 36: Latin America Molecular Imaging Market Value (USD billion), By Country/ Sub-region, 2024 & 2032
  • Figure 37: Latin America Molecular Imaging Market Value Share (%), By Country/ Sub-region, 2024
  • Figure 38: Middle East & Africa Molecular Imaging Market Value (USD billion), by Type, 2024 & 2032
  • Figure 39: Middle East & Africa Molecular Imaging Market Value Share (%), by Type, 2024
  • Figure 40: Middle East & Africa Molecular Imaging Market Value (USD billion), by Application, 2024 & 2032
  • Figure 41: Middle East & Africa Molecular Imaging Market Value Share (%), by Application, 2024
  • Figure 42: Middle East & Africa Molecular Imaging Market Value (USD billion), by End User, 2024 & 2032
  • Figure 43: Middle East & Africa Molecular Imaging Market Value Share (%), by End User, 2024
  • Figure 44: Middle East & Africa Molecular Imaging Market Value (USD billion), By Country/ Sub-region, 2024 & 2032
  • Figure 45: Middle East & Africa Molecular Imaging Market Value Share (%), By Country/ Sub-region, 2024
  • Figure 46: Global Molecular Imaging Market Share (%), By Company, 2024